Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaXavier C. Badoux, Alessandra Ferrajoli, Susan O’Brien et al.|Journal of Clinical Oncology|2012Cited by 153
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemiaXavier C. Badoux, William G. Wierda, Michael J. Keating et al.|Blood|2011Cited by 63
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical DevelopmentAndrew Davies, Xavier C. Badoux|Advances in Therapy|2017Cited by 63